Welcome to our dedicated page for General Enterprise Ventures SEC filings (Ticker: GEVID), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The General Enterprise Ventures, Inc. (GEVID) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as an SEC-reporting issuer incorporated in Wyoming. These documents include current reports on Form 8-K and amendments on Form 8-K/A that describe material definitive agreements, private placements and changes in board composition.
For GEVID, recent filings detail Securities Purchase Agreements for PIPE offerings of Series C Convertible Preferred Stock and associated PIPE Warrants. The company explains how each preferred share is convertible into common stock and how the PIPE Warrants are exercisable at a stated exercise price, with customary adjustments for stock splits and reorganizations. The filings also describe Placement Agent Warrants issued to Univest Securities, LLC, with exercise prices linked to the conversion price of the Series C Preferred Stock.
These reports specify that the preferred shares and warrants were offered only to accredited investors and issued in reliance on exemptions from registration under the Securities Act of 1933. They further note that there is no trading market for the Preferred Stock Shares or PIPE Warrants on any securities exchange or nationally recognized trading system, and that the company does not intend to list them.
Beyond financing transactions, GEVID’s Form 8-K filings also cover governance topics, such as the appointment of new directors with backgrounds in investment management, chemicals, specialty materials and industrial sectors. On Stock Titan, investors can review these filings alongside AI-powered summaries that highlight key terms, conversion features, warrant structures and board changes, helping to interpret how General Enterprise Ventures structures its capital and aligns its governance with its specialty chemicals and wildfire defense focus.
CitroTech Inc. director Jeffery Bruce Pomerantz filed an initial ownership report showing his stake in the company. The filing lists beneficial ownership of 41,667 shares of CitroTech common stock, held directly. This is a baseline disclosure of his position rather than a new buy or sell transaction.
CitroTech Inc. director Calinawan Lorenzo filed an initial ownership report on Form 3. The filing lists no buy, sell, acquisition, or disposition transactions and shows zero shares reported in each transaction category, indicating only a baseline disclosure of insider status at the company.
CitroTech Inc. filed an initial ownership report for Chief Operating Officer Andrew Hotsko. This Form 3 does not list any stock transactions or share amounts, and simply establishes his status as a reporting officer under insider ownership rules.
CitroTech Inc. executive Stephen Conboy, Chief Technology Officer, filed an amended Form 3 to update his reported equity holdings. He directly holds 2,666,667 shares of Series C Convertible Preferred Stock and 650,000 shares of common stock as of the reported date. Each Series C preferred share is convertible at the holder’s option into 3.3333 shares of common stock and has no expiration date.
CitroTech Inc. director and 10% owner Craig A. Huff reported indirect holdings in the company through BoltRock Holdings LLC. BoltRock holds 95,674 shares of Series C Convertible Preferred Stock, 2,416,667 shares of common stock, 302,526 shares of Series A Preferred Stock, a convertible note representing 833,334 shares of common stock, and warrants for 416,667 and 44,445 shares. Huff is BoltRock’s managing member and disclaims beneficial ownership beyond his pecuniary interest.
CitroTech Inc. insider Ralston Theodore filed an amended Form 3 to update his beneficial ownership. He indirectly holds 4,000,000 shares of Series C Convertible Preferred Stock through TC Special Investments LLC, where he has voting and dispositive control. He also directly owns 171,256 common shares and indirectly owns 333,280 common shares through his spouse. A footnote notes these amounts are adjusted for a 1-for-6 reverse stock split effective August 28, 2025.
CitroTech Inc. filed an insider ownership report for Bolsen Wesley James, who serves as both Chief Executive Officer and director. The filing lists him as a reporting person but shows no insider stock transactions or share movements, indicating this is a position-only disclosure without trade activity.
CitroTech Inc. is registering up to 8,154,280 shares of common stock for resale by existing stockholders. These shares include stock issued or issuable from prior private placements, convertible debt conversions and warrants. CitroTech will not receive cash from these resales, but may receive funds if warrants covered by the prospectus are exercised.
The company had 18,803,230 shares outstanding as of February 16, 2026, with a stated total of 26,957,510 shares outstanding after the offering. For the nine months ended September 30, 2025, CitroTech generated $1.95 million in revenue and recorded a net loss of $30.7 million, with an accumulated deficit of $107.1 million and a going concern warning from its auditors.
The business is highly leveraged, with about $2.49 million of debt as of December 31, 2025, and depends on a small number of customers and a five-person management team. Two preferred stockholders control roughly 99% of voting power through super-voting Series A preferred shares, qualifying CitroTech as a “controlled company” that uses NYSE American governance exemptions. The prospectus highlights significant risks, including volatile share price, potential dilution from preferred stock, warrants and options, regulatory and product-liability exposure in fire-retardant markets, and the need for continued external financing.
General Enterprise Ventures (GEVI)$288,212 for the quarter (vs. $107,042 a year ago) and reached $1,945,232 for the first nine months (vs. $738,729). Operating expenses were $4,525,910 in Q3, driving a loss from operations of $4,237,698. The company reported a Q3 net loss of $7,929,208 and a nine‑month net loss of $30,736,631.
Cash increased to $6,195,974 as of September 30, 2025 (from $775,133 at year‑end), supported by equity financings, including September 2025 proceeds of about $5.4 million and an additional October 2025 raise of about $2.7 million. The company withdrew a registration statement on August 19, 2025 and reclassified $1,604,000 of derivative liability to equity. A 1‑for‑6 reverse stock split became effective on August 27, 2025. Common shares outstanding were 17,552,912 as of November 12, 2025.
General Enterprise Ventures (GEVI) filed an amended Form 8-K to correct and clarify terms of its October 21, 2025 PIPE financing and related exhibits. The company sold 193,967 shares of Series C Convertible Preferred Stock for an aggregate purchase price of $2,909,515, each convertible into 3.3333 shares of common stock, and issued PIPE Warrants to purchase up to 323,276 common shares. The PIPE Warrants are exercisable immediately at an exercise price of $6.00 per share and expire five years from issuance.
The amendment restates that Placement Agent Warrants have an exercise price equal to 120% of the price per share of common stock issuable upon conversion of the Series C, set at $5.40 per share, and replaces exhibits to correct typographical errors. Univest Securities, LLC received a cash fee equal to 8% of gross proceeds and Placement Agent Warrants equal to 5% of the total common shares underlying the converted preferred and PIPE Warrants. The securities were offered only to accredited investors and were not registered under the Securities Act.